Talenti Gelato & Sorbetto, 1 pt. (473 mL) in clear plastic jars with best by date 5/19/2016, UPC 8685200024
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1923-2015.
Talenti Gelato & Sorbetto, a Unilever Company is voluntarily recalling a limited number of jars of Talenti Gelato & Sorbetto Sea Salt Carmel Gelato because they may inadvertently contain peanuts (as peanut butter) which are not listed as an ingredient on the label.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1923-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Unilever United States, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1923-2015.
Unilever United States, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Unilever United States, Inc. Recall FAQ
Unilever United States, Inc. is the subject of a food safety report: Talenti Gelato & Sorbetto, 1 pt. (473 mL) in clear plastic jars with best by date 5/19/2016, UPC 8685200024. The notice was published on February 27, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 5,810 units are potentially affected.